|
1.
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2.
|
O’Byrne KJ, Gatzemeier U, Bondarenko I, et
al: Molecular biomarkers in non-small-cell lung cancer: a
retrospective analysis of data from the phase 3 FLEX study. Lancet
Oncol. 12:795–805. 2011.PubMed/NCBI
|
|
3.
|
Douillard JY, Shepherd FA, Hirsh V, et al:
Molecular predictors of outcome with gefitinib and docetaxel in
previously treated non-small-cell lung cancer: data from the
randomized phase III INTEREST trial. J Clin Oncol. 28:744–752.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Komurcuoglu B, Ulusoy S, Gayaf M, et al:
Prognostic value of plasma D-dimer levels in lung carcinoma.
Tumori. 97:743–748. 2011.PubMed/NCBI
|
|
5.
|
Unsal E, Atalay F, Atikcan S and Yilmaz A:
Prognostic significance of hemostatic parameters in patients with
lung cancer. Respir Med. 98:93–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
van Doormaal FF, Raskob GE, Davidson BL,
et al: Treatment of venous thromboembolism in patients with cancer:
subgroup analysis of the Matisse clinical trials. Thromb Haemost.
101:762–769. 2009.PubMed/NCBI
|
|
7.
|
Monreal M, Fernandez-Llamazares J, Piñol
M, et al: Platelet count and survival in patients with colorectal
cancer - a preliminary study. Thromb Haemost. 79:916–918.
1998.PubMed/NCBI
|
|
8.
|
Costantini V, Zacharski LR, Moritz TE and
Edwards RL: The platelet count in carcinoma of the lung and colon.
Thromb Haemost. 64:501–505. 1990.PubMed/NCBI
|
|
9.
|
Shimada H, Oohira G, Okazumi S, et al:
Thrombocytosis associated with poor prognosis in patients with
esophageal carcinoma. J Am Coll Surg. 198:737–741. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Ikeda M, Furukawa H, Imamura H, et al:
Poor prognosis associated with thrombocytosis in patients with
gastric cancer. Ann Surg Oncol. 9:287–291. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Hwang SG, Kim KM, Cheong JH, et al: Impact
of pretreatment thrombocytosis on blood-borne metastasis and
prognosis of gastric cancer. Eur J Surg Oncol. 38:562–567. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Gonzalez Barcala FJ, Garcia Prim JM,
Moldes Rodriguez M, et al: Platelet count: association with
prognosis in lung cancer. Med Oncol. 27:357–362. 2010.PubMed/NCBI
|
|
13.
|
Gislason T and Nõu E: Sedimentation rate,
leucocytes, platelet count and haemoglobin in bronchial carcinoma:
an epidemiological study. Eur J Respir Dis. 66:141–146.
1985.PubMed/NCBI
|
|
14.
|
Engan T and Hannisdal E: Blood analyses as
prognostic factors in primary lung cancer. Acta Oncol. 29:151–154.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Pedersen LM and Milman N: Prognostic
significance of thrombocytosis in patients with primary lung
cancer. Eur Respir J. 9:1826–1830. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Aoe K, Hiraki A, Ueoka H, et al:
Thrombocytosis as a useful prognostic indicator in patients with
lung cancer. Respiration. 71:170–173. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Cox G, Walker RA, Andi A, et al:
Prognostic significance of platelet and microvessel counts in
operable non-small cell lung cancer. Lung Cancer. 29:169–177. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Tomita M, Shimizu T, Hara M, et al:
Prognostic impact of thrombocytosis in resectable non-small cell
lung cancer. Interact Cardiovasc Thorac Surg. 7:613–615. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Dineen SP, Roland CL, Toombs JE, et al:
The acellular fraction of stored platelets promotes tumor cell
invasion. J Surg Res. 153:132–137. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Pipili-Synetos E, Papadimitriou E and
Maragoudakis ME: Evidence that platelets promote tube formation by
endothelial cells on matrigel. Br J Pharmacol. 125:1252–1257. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Placke T, Kopp HG and Salih HR: Modulation
of natural killer cell anti-tumor reactivity by platelets. J Innate
Immun. 3:374–382. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Nieswandt B, Hafner M, Echtenacher B and
Männel DN: Lysis of tumor cells by natural killer cells in mice is
impeded by platelets. Cancer Res. 59:1295–1300. 1999.PubMed/NCBI
|
